Background:
Some patients with type 1 diabetes mellitus have not good glycaemic control with ordinary doses of insulin. So applying other treatment modality in addition to insulin and diet therapy could improve glycaemic control.
Shiraz E-Medical Journal
Some patients with type 1 diabetes mellitus have not good glycaemic control with ordinary doses of insulin. So applying other treatment modality in addition to insulin and diet therapy could improve glycaemic control.
To evaluate whether, in patients with type 1 diabetes mellitus, the addition of Metformin to insulin and standard diabetes management result in better glycaemic control and lower insulin dosage .
In a clinical trial study 16 children and adolescents with type 1 diabetes with had high insulin intake and HbA1c >8% were participated. HbA1c, FBS, 2hpp BG, insulin dosage and BMI were measured and compared at the onset and end of the treatment.
There were significant differences in HbA1c and insulin dosage between the time of 0 of the study and after 4 months of Metformin addition therapy. But there were no significant differences between BMI, FBG and 2 h pp BG at the onset of the study and end of it.
Metformin treatment lowered HbA1c and decreased insulin dosage in patients with type 1 diabetes in poor metabolic control. Long term studies will determine if these improvements are sustained.
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Setoodeh A, Rostami P, Rabbani A, Nakhaei-Moghadam M, Najmi-Varzaneh F, et al. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Inn J Pediatr. 2014;24(2):. doi:
Razzaghy-Azar M, Momeni H, Nourbakhsh M, Nourbakhsh M, Talebi A, et al. Comparison of Insulin Glargine and Detemir Effects on Hormones of Appetite and Metabolic Control in Patients with Type 1 Diabetes: A Randomized Clinical Trial. Iran J Pharm Res. 2021;20(3):e124482. doi: https://doi.org/10.22037/ijpr.2021.114841.15059
Gheini S, Hosseini M, Rezaei M. Association between HbA1C value at the time of diagnosis and response rate to treatment in children with type I diabetes mellitus. J Kermanshah Univ Med Sci. 2014;18(6):e74084. doi: https://doi.org/10.22110/jkums.v18i6.1671
Kavthekar SO, Mali VT, Verma S, Kurane AB, Patil NB, et al. Evaluation of Microalbuminuria and Glycosylated Hemoglobin in the Assessment of Diabetes Control in Children with Type 1 Diabetes Mellitus Hospitalized with Diabetic Ketoacidosis. J Compr Ped. 2021;12(2):e109904. doi: https://doi.org/10.5812/compreped.109904
Otto-Buczkowska E, Jainta N. Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?. Int J Endocrinol Metab. 2018;16(1):e13008. doi: https://doi.org/10.5812/ijem.13008
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):